{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-079163","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.688886+00:00","generated_at":"2026-05-15T23:05:02.576743+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Treace Medical Q4 revenue $62.5M (-9% YoY); guides FY2026 revenue down 0-6%","bullets":["Q4 revenue $62.5M, down 9% YoY; net loss $(9.4)M vs $(0.5)M in prior year.","FY2025 revenue $212.7M, up 2% YoY; net loss $(59.0)M vs $(55.7)M; adj. EBITDA loss $(3.9)M.","Guidance: FY2026 revenue $200-212M (decline 0-6%); adj. EBITDA loss $4-6M.","Cash used fell 46% to $27.3M in FY2025; active surgeons +6% to 3,337."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-079163","json":"https://secwatch.observer/filing/0001193125-26-079163.json","markdown":"https://secwatch.observer/filing/0001193125-26-079163.md","text":"https://secwatch.observer/filing/0001193125-26-079163.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526079163/0001193125-26-079163-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526079163/tmci-20260227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:05:02.576743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}